Bioaffinity Technologiew-27BIAFWPreferred / convertible
13F holders, Q2 2026 (June 30)4holders
0new positions
0sold out
1famous investor
$0.14avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding Bioaffinity Technologiew-27 (BIAFW) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were Clear Street Group Inc. ($8K), UBS Group AG ($7K) and Citadel Advisors ($2K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologiew-27
- CUSIP
- 09076W117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 503 shares bought and 2,688 shares sold, net −2,185 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Clear Street Group Inc. | — | No change | 54,927 | $8K |
| UBS Group AG | — | Add +0.7% | 46,445 | $7K |
| Citadel Advisors | — | Reduce -13.5% | 17,162 | $2K |
| Susquehanna International Group, LLP | — | Add +1.5% | 11,180 | $2K |
"% of holder's portfolio" is BIAFW's weight in each manager's 13F, not the share of Bioaffinity Technologiew-27 the manager owns.